Breaking News

Mylan to Acquire Bioniche Injectable Business

Mylan, Inc. has plans to acquire Bioniche Pharma Holdings Ltd., a global injectable pharmaceutical company, for $550 million in cash.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mylan, Inc. has plans to acquire Bioniche Pharma Holdings Ltd., a global injectable pharmaceutical company, for $550 million in cash. Bioniche Pharma will provide Mylan with immediate entry into the North American injectables market, as well as a platform for future growth opportunities. Mylan chairman and chief executive officer Robert J. Coury said: “We are extremely pleased to be adding this complementary, high growth, high margin business to our one-of-a-kind global pharmaceutical ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters